NSF SBIR/STTR
Early-stage technology R&D with commercial potential, including life-science tools and medical technologies.
Selected NIH SBIR/STTR, NSF, and other non-dilutive funding opportunities for biotech and life-science companies, with application deadlines and planning timelines.
Early-stage technology R&D with commercial potential, including life-science tools and medical technologies.
Company-led research to establish feasibility and develop biomedical products for commercialization.
Biomedical product development through a small-business partnership with a nonprofit research institution.
NSF 26-510 · Application deadline
5 p.m. applicant organization’s local time
September 14 is a Noradelis suggestion for applicants already positioned to submit. A new Project Pitch may not receive an invitation in time for November; March 4, 2027 is the next listed deadline. Later stages have no fixed calendar dates here.
Full solicitation · NSF 26-510 ↗PA-27-100 · Application deadline
5 p.m. applicant organization’s local time
Preparation start is a Noradelis suggestion. Review and earliest start dates follow the announcement and may change; an award is not guaranteed. Timeline not to scale.
Full announcement · PA-27-100 ↗PA-27-102 · Application deadline
5 p.m. applicant organization’s local time
Preparation start is a Noradelis suggestion. Review and earliest start dates follow the announcement and may change; an award is not guaranteed. Timeline not to scale.
Full announcement · PA-27-102 ↗Your next funding decision
Tell us what your company is pursuing, where you are in the process, and what decision or review you need help with.
Discuss your funding strategy